Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors

Keiji Tanese, Katsura Emoto, Naoto Kubota, Mariko Fukuma, Michiie Sakamoto

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Activation of the Hedgehog (HH) signaling pathway plays a critical role in the development of basal cell carcinoma (BCC). HH signaling activity is produced by nuclear translocation of transcription factors, glioma-associated oncogene homolog (GLI). Among three GLI subfamilies, GLI1 is the only full-length transcriptional activator, and its nuclear localization is recognized as a signature event in HH signaling activation. However, limited published work has investigated the nuclear staining of GLI1 protein in human tumor tissue samples by immunohistochemical analysis. In this study, we performed immunohistochemical staining of GLI1 in 382 cases of cutaneous epithelial tumors, including 196 BCC cases, using rabbit monoclonal antihuman GLI1 antibody (C68H3). As a result, 98.2% cases of BCC showed a diffuse and strong nuclear staining pattern regardless of the histological subtype. Positive staining was mainly restricted to the tumor nests, while the overlying epidermis was negative suggesting specificity of the antibody. In further analysis of other cutaneous epithelial tumors, 100% (4/4) cases of trichoblastoma, 15.1% (5/33) Bowen's disease, 3.5% (1/28) actinic keratosis and 12.5% (4/32) squamous cell carcinoma showed the nuclear staining pattern of GLI1. This suggested that HH signaling is also dysregulated in some other cutaneous malignant tumors. In conclusion, the C68H3 antibody is a useful tool for revealing activation of HH signaling in immunohistochemical analysis.

Original languageEnglish
JournalJournal of Dermatology
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Hedgehogs
Staining and Labeling
Basal Cell Carcinoma
Skin
Neoplasms
Bowen's Disease
Actinic Keratosis
Antibody Specificity
Antibodies
Oncogenes
Epidermis
Glioma
Squamous Cell Carcinoma
Transcription Factors
Rabbits

Keywords

  • Basal cell carcinoma
  • Bowen's disease
  • GLI1
  • Hedgehog signaling pathway
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Dermatology

Cite this

@article{f230167f09794fae8f63cb2be6697b8f,
title = "Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors",
abstract = "Activation of the Hedgehog (HH) signaling pathway plays a critical role in the development of basal cell carcinoma (BCC). HH signaling activity is produced by nuclear translocation of transcription factors, glioma-associated oncogene homolog (GLI). Among three GLI subfamilies, GLI1 is the only full-length transcriptional activator, and its nuclear localization is recognized as a signature event in HH signaling activation. However, limited published work has investigated the nuclear staining of GLI1 protein in human tumor tissue samples by immunohistochemical analysis. In this study, we performed immunohistochemical staining of GLI1 in 382 cases of cutaneous epithelial tumors, including 196 BCC cases, using rabbit monoclonal antihuman GLI1 antibody (C68H3). As a result, 98.2{\%} cases of BCC showed a diffuse and strong nuclear staining pattern regardless of the histological subtype. Positive staining was mainly restricted to the tumor nests, while the overlying epidermis was negative suggesting specificity of the antibody. In further analysis of other cutaneous epithelial tumors, 100{\%} (4/4) cases of trichoblastoma, 15.1{\%} (5/33) Bowen's disease, 3.5{\%} (1/28) actinic keratosis and 12.5{\%} (4/32) squamous cell carcinoma showed the nuclear staining pattern of GLI1. This suggested that HH signaling is also dysregulated in some other cutaneous malignant tumors. In conclusion, the C68H3 antibody is a useful tool for revealing activation of HH signaling in immunohistochemical analysis.",
keywords = "Basal cell carcinoma, Bowen's disease, GLI1, Hedgehog signaling pathway, Squamous cell carcinoma",
author = "Keiji Tanese and Katsura Emoto and Naoto Kubota and Mariko Fukuma and Michiie Sakamoto",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/1346-8138.14543",
language = "English",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors

AU - Tanese, Keiji

AU - Emoto, Katsura

AU - Kubota, Naoto

AU - Fukuma, Mariko

AU - Sakamoto, Michiie

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Activation of the Hedgehog (HH) signaling pathway plays a critical role in the development of basal cell carcinoma (BCC). HH signaling activity is produced by nuclear translocation of transcription factors, glioma-associated oncogene homolog (GLI). Among three GLI subfamilies, GLI1 is the only full-length transcriptional activator, and its nuclear localization is recognized as a signature event in HH signaling activation. However, limited published work has investigated the nuclear staining of GLI1 protein in human tumor tissue samples by immunohistochemical analysis. In this study, we performed immunohistochemical staining of GLI1 in 382 cases of cutaneous epithelial tumors, including 196 BCC cases, using rabbit monoclonal antihuman GLI1 antibody (C68H3). As a result, 98.2% cases of BCC showed a diffuse and strong nuclear staining pattern regardless of the histological subtype. Positive staining was mainly restricted to the tumor nests, while the overlying epidermis was negative suggesting specificity of the antibody. In further analysis of other cutaneous epithelial tumors, 100% (4/4) cases of trichoblastoma, 15.1% (5/33) Bowen's disease, 3.5% (1/28) actinic keratosis and 12.5% (4/32) squamous cell carcinoma showed the nuclear staining pattern of GLI1. This suggested that HH signaling is also dysregulated in some other cutaneous malignant tumors. In conclusion, the C68H3 antibody is a useful tool for revealing activation of HH signaling in immunohistochemical analysis.

AB - Activation of the Hedgehog (HH) signaling pathway plays a critical role in the development of basal cell carcinoma (BCC). HH signaling activity is produced by nuclear translocation of transcription factors, glioma-associated oncogene homolog (GLI). Among three GLI subfamilies, GLI1 is the only full-length transcriptional activator, and its nuclear localization is recognized as a signature event in HH signaling activation. However, limited published work has investigated the nuclear staining of GLI1 protein in human tumor tissue samples by immunohistochemical analysis. In this study, we performed immunohistochemical staining of GLI1 in 382 cases of cutaneous epithelial tumors, including 196 BCC cases, using rabbit monoclonal antihuman GLI1 antibody (C68H3). As a result, 98.2% cases of BCC showed a diffuse and strong nuclear staining pattern regardless of the histological subtype. Positive staining was mainly restricted to the tumor nests, while the overlying epidermis was negative suggesting specificity of the antibody. In further analysis of other cutaneous epithelial tumors, 100% (4/4) cases of trichoblastoma, 15.1% (5/33) Bowen's disease, 3.5% (1/28) actinic keratosis and 12.5% (4/32) squamous cell carcinoma showed the nuclear staining pattern of GLI1. This suggested that HH signaling is also dysregulated in some other cutaneous malignant tumors. In conclusion, the C68H3 antibody is a useful tool for revealing activation of HH signaling in immunohistochemical analysis.

KW - Basal cell carcinoma

KW - Bowen's disease

KW - GLI1

KW - Hedgehog signaling pathway

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85050934738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050934738&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.14543

DO - 10.1111/1346-8138.14543

M3 - Article

C2 - 30035333

AN - SCOPUS:85050934738

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

ER -